Back | Next |
home / stock / chma / chma message board
Subject | By | Source | When |
---|---|---|---|
CHMA is very undervalued, considered the Cash/Book above | kany | investorshub | 07/06/2016 6:30:30 PM |
CHMA is very undervalued, considered the Cash/Book above | kany | investorshub | 07/06/2016 6:29:35 PM |
Difficult chowdhury ji .. I am happy | Jumboo | investorshub | 06/16/2016 9:38:37 PM |
When would we see $10 a share again? | Shane Chowdhury | investorshub | 06/15/2016 6:24:10 AM |
Wait it out Good entry here for a | blue finch | investorshub | 05/05/2016 10:52:03 AM |
Thoughts here | Jumboo | investorshub | 05/04/2016 8:58:02 PM |
They have plenty of $$ They are meeting the | blue finch | investorshub | 04/22/2016 5:06:29 PM |
I have three stocks about to break major | XenaLives | investorshub | 04/22/2016 5:02:32 PM |
Poor management Unaware more trials required By FDA Possible bounce soon Stay | blue finch | investorshub | 04/22/2016 4:53:02 PM |
Has anyone done any DD here???? | XenaLives | investorshub | 04/22/2016 1:23:24 PM |
sold my position and bought ensco (esv) @ | gregque | investorshub | 04/21/2016 3:29:42 PM |
RSI 24... Way over sold .. Bounce is coming | Jumboo | investorshub | 04/20/2016 6:04:54 PM |
Time for bounce ... Over sold ... | Jumboo | investorshub | 04/20/2016 5:31:40 PM |
The accumulation phase is almost over The washout - | blue finch | investorshub | 04/20/2016 12:25:55 PM |
i have no stake in this myself just | PStockPickz | investorshub | 04/19/2016 2:45:41 PM |
Glad having bought at 8.5 and sold at | ramalio | investorshub | 04/19/2016 1:17:17 PM |
Check out the seeking alpha piece today | blue finch | investorshub | 04/19/2016 12:49:51 PM |
i will wait and see how this looks | PStockPickz | investorshub | 04/18/2016 7:26:21 PM |
6 million and counting Wont see this tomorrow guaranteed | blue finch | investorshub | 04/18/2016 6:58:19 PM |
Ok here | blue finch | investorshub | 04/18/2016 6:26:01 PM |
News, Short Squeeze, Breakout and More Instantly...
Pulmatrix appoints Director Anand Varadan PR Newswire LEXINGTON, Mass. , July 27, 2021 /PRNewswire/ -- Pulmatrix, Inc. (NASDAQ: PULM), a clinical-stage biopharmaceutical company developing innovative inhaled therapies to address serious pulmonary and...
NEEDHAM, Mass., June 28, 2021 (GLOBE NEWSWIRE) -- Chiasma, Inc. (NASDAQ: CHMA), (“Chiasma” or the “Company”), a commercial-stage biopharmaceutical company utilizing its delivery platform technology to develop and commercialize oral therapies to improve the lives ...
NEEDHAM, Mass., May 27, 2021 (GLOBE NEWSWIRE) -- Chiasma, Inc. (NASDAQ: CHMA), (“Chiasma” or the “Company”) today presented patient-reported outcomes (PROs) data from its MPOWERED™ Phase 3 trial demonstrating that study patients with acromegaly reported si...